TS
Two Seas Capital LP disclosed a 9.8% stake in NKTR
Two Seas Capital LP reported owning 9.8% of Nektar Therapeutics (NKTR) (3,345,978 shares) in a Schedule 13G filed Sep 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.